A 62-year old female presented with generalized erythematous papules and nodules on the trunk and limbs for two weeks. On physical examination, multiple, non-tender, erythematous papules and nodules, diameters ranging from 0.3 to 1cm were observed on the trunk and extremities (Fig. 1) .
can be seen simultaneously, after or prior to the diagnosis of underlying leukaemia (2) .
Skin manifestations of leukaemia are classified into two groups: specific and non-specific. Specific findings called leukaemia cutis are due to leukaemic infiltration of the skin and usually seen as localized or disseminated papules, nodules and plaques with violaceous or reddish-brown colour (3). Non-specific skin manifestations may include maculopapular rash, purpura, excoriation, secondary skin infections, and reactive dermatoses such as Sweet's Syndrome and pyoderma gangrenosum (1) .
Diagnosis of LC is based on skin biopsy, immunophenotyping, and B or T cell receptor rearrangement studies. Peripheral blood smear and bone marrow biopsy also help in the diagnosis. Histopathology of myeloid LC shows immature myeloid cells that are usually located in the dermis and subcutis with sparing of the upper papillary dermis (4).
There is no specific treatment for LC; the treatment of the underlying leukaemia improves the skin lesions (5). Radiotherapy and whole-body electron-beam irradiation are also considered as alternative treatments for widespread or resistant skin involvement. Leukaemia cutis indicates poor prognosis (3, 5) .
In our patient, skin lesions were the first sign of underlying leukaemia. The patient was referred to the haematology clinic, but died after one week, while receiving chemotherapy, probably, due to blast crisis. Consideration of LC in the differential diagnosis of suddenly emerged generalized nodules is important to reduce morbidity and mortality. The routine laboratory investigations were; white blood cell: 108.8 x10 9 /L, haemoglobin: 6.3 g/dL, platelet: 105 x 10 9 /L and lactate dehydrogenase (LDH): 568 U/L. The diagnosis of leukaemia was considered with laboratory tests. Peripheral blood smear showed blast cells. Bone marrow cytology was compatible with the peripheral blood smear. In the flow cytometry, morphologically atypical monoblasts and myeloblasts were located in the granulocyte/monocyte region (85%). High expressions of CD13, CD33, CD11b, CD14, myeloperoxidase and human leukocyte antigen -antigen D related (HLA-DR) were detected. A punch biopsy was taken from the skin lesions. The biopsy specimen showed an atypical cellular infiltration diffusely located in the dermis sparing of the upper papillary dermis.
Immunohistochemical stains were positive for leukocyte common antigen [LCA] (Fig. 2) and negative for pancytokeratin.
Leukaemia cutis (LC) with the French-American-British (FAB) classification systems subtype acute myeloid leukaemia-M4 (AML-M4) was diagnosed with these findings.
Leukaemia cutis (LC) is the infiltration of leukaemic cells into the epidermis, dermis, or subcutis (1). Incidence of LC varies from less than 5% to 40%. Cutaneous involvement is more common in the M4 and M5 subtypes of AML. Generally, LC occurs after diagnosis of myeloid leukaemia, but it
